The Board of Directors of Pasithea Therapeutics Corp. has authorized a buyback plan on July 20, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.58 USD | -1.05% | -14.32% | -11.08% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.08% | 6.93M | |
+7.72% | 113B | |
+10.94% | 106B | |
+0.41% | 22.27B | |
-11.91% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.57% | 17.24B | |
+6.72% | 14.29B | |
+35.67% | 12.52B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp. authorizes a Buyback Plan.